AIAxsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and delivering novel therapies for central nervous system (CNS) disorders with limited treatment options. The company aims to transform the approach to treating CNS conditions by developing therapeutic options with innovative mechanisms of action.
APAlexion Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing therapies for rare diseases.
AIAcadia Pharmaceuticals is dedicated to pioneering innovative therapies for neurological disorders, focusing on elevating the lives of patients through dedicated research and community support.
JPJazz Pharmaceuticals is a global biopharmaceutical company focused on developing innovative medicines to improve patients' lives.
Ultragenyx Pharmaceutical Inc. develops innovative medicines for rare and ultrarare diseases, focusing on transformative therapies across multiple indications.
APApellis Pharmaceuticals is a biopharmaceutical company specializing in targeted therapies for diseases impacted by the complement system.